Literature DB >> 12684262

Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.

Linda Cleary1, Catherine Vandeputte, James R Docherty.   

Abstract

1. The subtypes of alpha(1)- and alpha(2)-adrenoceptor mediating contractions of vas deferens have been examined in wild-type and alpha(2A/D)-adrenoceptor knockout mice. 2. Maximum contractions to noradrenaline but not phenylephrine were significantly greater in vas from wild-type. The alpha(1A)-adrenoceptor antagonist RS100329 (5-methyl-3-[3-[4-[2-(2,2,2,-trifluoroethoxy)phenyl]-1-piperazinyl]propyl]-2,4-(1H)-pyrimidinedione) (10 nM) significantly shifted the potency of noradrenaline. The alpha(2D)-adrenoceptor antagonist BRL 44408 (2-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole) significantly reduced the maximum contraction to noradrenaline in wild-type but not in knockout. 3. Following prazosin (0.1 micro M), a component of the contraction to noradrenaline in wild-type but not in knockout was sensitive to the alpha(2)-adrenoceptor antagonist yohimbine. 4. Nifedipine (10 micro M) or suramin (100 micro M) reduced the contraction to 10 Hz stimulation for 4 s to an early peak and small maintained response. The peak was abolished by the alpha(1)-adrenoceptor antagonist prazosin. 5. RS100329 or prazosin inhibited 10 Hz stimulation evoked contractions with a U-shaped concentration-response curve: inhibiting responses up to 0.1 micro M, with a reversal of inhibition above this concentration. In the presence of suramin or nifedipine, the reversal of inhibition by high concentrations of prazosin was reduced. 6. The alpha(1D)-adrenoceptor selective antagonist BMY7378 (8-[2-(4-(2- methoxyphenyl)piperazin-1-yl)ethyl]-8-azaspiro[4,5]decane-7,9-dione) produced inhibition of 10 Hz evoked contractions only in high concentrations. 7. In conclusion, contractions to nerve stimulation in mouse vas deferens involve largely alpha(1A)-adrenoceptors and purinoceptors. alpha(1)-Adrenoceptor antagonists in high concentrations increase the purinergic response presumably by blocking prejunctional alpha(2)-adrenoceptor-mediated inhibition. In the presence of nifedipine, responses are predominantly alpha(1)-adrenoceptor mediated. Contractions to exogenous noradrenaline involved both alpha(1A)- and alpha(2A/D)-adrenoceptors in wild-type mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684262      PMCID: PMC1573749          DOI: 10.1038/sj.bjp.0705137

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat vas deferens.

Authors:  V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.

Authors:  K Rajamani; S Leong; A Lavelle; J R Docherty
Journal:  Eur J Pharmacol       Date:  2001-07-06       Impact factor: 4.432

3.  Further examination of the inhibitory actions of alpha 1-adrenoceptor agonists in rat vas deferens.

Authors:  P Warnock; L Hyland; J R Docherty
Journal:  Eur J Pharmacol       Date:  1985-07-17       Impact factor: 4.432

4.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

5.  Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

Authors:  S Cotecchia; D A Schwinn; R R Randall; R J Lefkowitz; M G Caron; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.

Authors:  L Hein; J D Altman; B K Kobilka
Journal:  Nature       Date:  1999-11-11       Impact factor: 49.962

7.  Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle.

Authors:  C Han; P W Abel; K P Minneman
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

8.  Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.

Authors:  J D Altman; A U Trendelenburg; L MacMillan; D Bernstein; L Limbird; K Starke; B K Kobilka; L Hein
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

9.  Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission.

Authors:  R J Allcorn; T C Cunnane; K Kirkpatrick
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

10.  The actions of cirazoline on the rat vas deferens.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

View more
  12 in total

1.  The sources and sequestration of Ca(2+) contributing to neuroeffector Ca(2+) transients in the mouse vas deferens.

Authors:  Keith L Brain; Alina M Cuprian; Damian J Williams; Thomas C Cunnane
Journal:  J Physiol       Date:  2003-09-18       Impact factor: 5.182

2.  Alpha(1A)-adrenoceptors mediate contractions to phenylephrine in rabbit penile arteries.

Authors:  J S Morton; C J Daly; V M Jackson; J C McGrath
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

3.  Alpha(2A)-adrenoceptors regulate sympathetic transmitter release in mice kidneys.

Authors:  O Vonend; S Habbel; J Stegbauer; J Roth; L Hein; L C Rump
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

4.  Alpha1-adrenoceptors are required for normal male sexual function.

Authors:  A Sanbe; Y Tanaka; Y Fujiwara; H Tsumura; J Yamauchi; S Cotecchia; K Koike; G Tsujimoto; A Tanoue
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

5.  Role of alpha2A-adrenoceptors in the effects of MDMA on body temperature in the mouse.

Authors:  Sotiria Bexis; James R Docherty
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Use of knockout technology to resolve pharmacological problems.

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2006-11-13       Impact factor: 8.739

7.  Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse.

Authors:  S Bexis; J R Docherty
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

8.  Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1 mg/kg.

Authors:  Dmitry V Zaretsky; Maria V Zaretskaia; Joseph A DiMicco; Daniel E Rusyniak
Journal:  Neurosci Lett       Date:  2015-09-12       Impact factor: 3.046

9.  Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate.

Authors:  Lauren K Parker; Julia A Shanks; James A G Kennard; Keith L Brain
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

10.  Physiological and pharmacological aspects of the vas deferens-an update.

Authors:  David S Koslov; Karl-Erik Andersson
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.